# EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

NDC: 69097-741
Generic name: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20211101

FDA application: ANDA090958

## Active ingredients

- EMTRICITABINE: 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-741"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-741
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d08c9455-e788-435c-9076-2bdb1a4f5b37